Director
Bristol Myers Squibb Company
New Brunswick, New Jersey
Peter Tattersall, Ph.D. is a Director in Analytical and Bioanalytical Development department within Pharmaceutical Development at Bristol-Myers Squibb Company in New Jersey. He received his BSc. and Ph.D. from the University of Manchester, UK. He previously worked in Analytical Development at AstraZeneca, Wilmington. He joined Bristol-Myers Squibb in 2003 where he is an analytical team leader within Chemical and Synthetic Development. He supervises a group of analytical chemists supporting small molecule synthesis development and who work on method development, risk assessments, transfer and validation in support of clinical and commercial (PPQ) drug substance supply.
Disclosure information not submitted.
From ATP to QC: A Risk-Based Assessment Workflow to Enables Robust Commercial Analytical Methods
Wednesday, July 15, 2026
10:30 AM - 11:00 AM East Coast USA Time